We collated contact tracing data from COVID-19 clusters in Singapore and Tianjin, China and
estimated the extent of pre-symptomatic transmission by estimating incubation periods and …

Background As the COVID-19 epidemic is spreading, incoming data allows us to quantify
values of key variables that determine the transmission and the effort required to control the …

COVID-19 remains a major public health concern, with large resurgences even where there
has been widespread uptake of vaccines. Waning immunity and the emergence of new …

Extensive non-pharmaceutical and physical distancing measures are currently the primary
interventions against coronavirus disease 2019 (COVID-19) worldwide. It is therefore urgent …

Genomic technologies have led to tremendous gains in understanding how pathogens
function, evolve and interact. Pathogen diversity is now measurable at high precision and …

The seasonal influenza (flu) vaccine is designed to protect against those influenza viruses
predicted to circulate during the upcoming flu season, but identifying which viruses are likely …

Following successful non-pharmaceutical interventions (NPI) aiming to control COVID-19,
many jurisdictions reopened their economies and borders. As little immunity had developed in …

Outbreaks of tuberculosis (TB) – such as the large isoniazid-resistant outbreak centred on
London, UK, which originated in 1995 – provide excellent opportunities to model transmission …

The celebrated Abakaliki smallpox data have appeared numerous times in the epidemic
modelling literature, but in almost all cases only a specific subset of the data is considered. The …

Serial intervals – the time between symptom onset in infector and infectee – are a fundamental
quantity in infectious disease control. However, their estimation requires knowledge of …